Employing Piezoelectric Mg 2+ ‐Doped Hydroxyapatite to Target Death Receptor‐Mediated Necroptosis: A Strategy for Amplifying Immune Activation
Open Access
- 22 January 2024
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 11 (13) , e2307130
Abstract
Although immunogenic cell death (ICD) inducers evidently enhance the effectiveness of immunotherapy, their potential is increasingly restricted by the development of apoptosis resistance in tumor cells, poor immunogenicity, and low T‐cell immune responsiveness. In this study, for the first time, piezoelectrically catalyzed Mg 2+ ‐doped hydroxyapatite (Mg‐HAP) nanoparticles, which are coated with a mesoporous silica layer and loaded with ONC201 as an agonist to specifically target the death receptor DR5 on tumor cells, ultimately developing an Mg‐HAP@MS/ONC201 nanoparticle (MHMO NP) system, are engineered. Owing to its excellent piezoelectric properties, MHMO facilitates the release of a significant amount of reactive oxygen species and Ca 2+ within tumor cells, effectively promoting the upregulation of DR5 expression and inducing tumor cell necroptosis to ultimately overcome apoptosis resistance. Concurrently, Mg 2+ released in the tumor microenvironment promotes CD8 + T receptor activation in response to the antitumor immune reaction induced by ICD. Using RNA‐seq analysis, it is elucidated that MHMO can activate the NF‐κB pathway under piezoelectric catalysis, thus inducing M1‐type macrophage polarization. In summary, a dual‐targeting therapy system that targets both tumor cells and the tumor microenvironment under piezoelectric catalysis is designed. This system holds substantial potential for advancements in tumor immunotherapy.Keywords
Funding Information
- Natural Science Foundation of Heilongjiang Province (LH2023H093, ZD2019E004)
- Natural Science Foundation of Shandong Province (ZR2019ZD29)
- National Natural Science Foundation of China (51972076)
This publication has 65 references indexed in Scilit:
- Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell ImmunotherapyCancer Cell, 2013
- SMIP-016 in Action: CD37 as a Death ReceptorCancer Cell, 2012
- Apoptotic volume decrease as a geometric determinant for cell dismantling into apoptotic bodiesCell Death & Differentiation, 2010
- CCL5 as an adjuvant for cancer immunotherapyExpert Opinion on Biological Therapy, 2010
- Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration featuresCell Death & Differentiation, 2009
- Multifunctional Hydroxyapatite Nanofibers and Microbelts as Drug CarriersChemistry – A European Journal, 2009
- Cooperation of the Agonistic DR5 Antibody Apomab with Chemotherapy to Inhibit Orthotopic Lung Tumor Growth and Improve SurvivalClinical Cancer Research, 2008
- Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrierBiomaterials, 2008
- Antigen-Presentation Properties of Plasmacytoid Dendritic CellsImmunity, 2008
- Endoplasmic reticulum calcium pool depletion-induced apoptosis is coupled with activation of the death receptor 5 pathwayOncogene, 2002